157 related articles for article (PubMed ID: 38439045)
1. The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma.
Xue C; Gu X; Shi Q; Ma X; Jia J; Su Y; Bao Z; Lu J; Li L
J Transl Med; 2024 Mar; 22(1):237. PubMed ID: 38439045
[TBL] [Abstract][Full Text] [Related]
2. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
3. Overview of microbial profiles in human hepatocellular carcinoma and adjacent nontumor tissues.
He Y; Zhang Q; Yu X; Zhang S; Guo W
J Transl Med; 2023 Feb; 21(1):68. PubMed ID: 36732743
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.
Peng L; Pan B; Zhang X; Wang Z; Qiu J; Wang X; Tang N
Cell Biol Toxicol; 2022 Dec; 38(6):1159-1173. PubMed ID: 35438468
[TBL] [Abstract][Full Text] [Related]
5. Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma.
Kumar M; Kaur R; Kanthaje S; Dhiman RK; Chakraborti A
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5823-5839. PubMed ID: 36583742
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor protects mice against hepatocellular carcinoma by ameliorating intestinal dysbiosis and attenuating inflammation.
Wu YN; Zhang L; Chen T; Li X; He LH; Liu GX
World J Gastroenterol; 2020 Sep; 26(36):5420-5436. PubMed ID: 33024394
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
9. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
[TBL] [Abstract][Full Text] [Related]
11. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma.
Yang J; He Q; Lu F; Chen K; Ni Z; Wang H; Zhou C; Zhang Y; Chen B; Bo Z; Li J; Yu H; Wang Y; Chen G
Gut Microbes; 2023; 15(1):2201159. PubMed ID: 37089022
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter infection in hepatocellular carcinoma tissue.
Xuan SY; Li N; Qiang X; Zhou RR; Shi YX; Jiang WJ
World J Gastroenterol; 2006 Apr; 12(15):2335-40. PubMed ID: 16688821
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinoma.
Ni J; Fu C; Huang R; Li Z; Li S; Cao P; Zhong K; Ge M; Gao Y
Lett Appl Microbiol; 2021 Jul; 73(1):73-80. PubMed ID: 33768575
[TBL] [Abstract][Full Text] [Related]
14. Characterization of disease-associated microbiota in hepatocellular carcinoma.
Sun P; Li Z; Zhang B
J Cancer Res Ther; 2023 Aug; 19(4):881-891. PubMed ID: 37675712
[TBL] [Abstract][Full Text] [Related]
15. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.
Budhu A; Roessler S; Zhao X; Yu Z; Forgues M; Ji J; Karoly E; Qin LX; Ye QH; Jia HL; Fan J; Sun HC; Tang ZY; Wang XW
Gastroenterology; 2013 May; 144(5):1066-1075.e1. PubMed ID: 23376425
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
17. Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma.
Huo R; Chen Y; Li J; Xu Q; Guo J; Xu H; You Y; Zheng C; Chen Y
Curr Oncol; 2023 Feb; 30(2):1818-1830. PubMed ID: 36826102
[TBL] [Abstract][Full Text] [Related]
18. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
Effenberger M; Waschina S; Bronowski C; Sturm G; Tassiello O; Sommer F; Zollner A; Watschinger C; Grabherr F; Gstir R; Grander C; Enrich B; Bale R; Putzer D; Djanani A; Moschen AR; Zoller H; Rupp J; Schreiber S; Burcelin R; Lass-Flörl C; Trajanoski Z; Oberhuber G; Rosenstiel P; Adolph TE; Aden K; Tilg H
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314752
[TBL] [Abstract][Full Text] [Related]
19. Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; He J; Zeng HY; Zhu XD
Oncologist; 2011; 16(7):1028-39. PubMed ID: 21665914
[TBL] [Abstract][Full Text] [Related]
20. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma.
Chai X; Wang J; Li H; Gao C; Li S; Wei C; Huang J; Tian Y; Yuan J; Lu J; Gao D; Zheng Y; Huang C; Zhou J; Shi G; Ke A; Liu F; Fan J; Cai J
Gut Microbes; 2023; 15(1):2156255. PubMed ID: 36563106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]